Mrs Anne Yu Buettner, MA | |
714 South Broadwell Avenue, Grand Island, NE 68803-6243 | |
(308) 383-7000 | |
(308) 384-7968 |
Full Name | Mrs Anne Yu Buettner |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 714 South Broadwell Avenue, Grand Island, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023232725 | NPI | - | NPPES |
10025070400 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 002 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Anne Yu Buettner, MA 714 S Broadwell Ave, Grand Island, NE 68803-6243 Ph: (308) 383-7000 | Mrs Anne Yu Buettner, MA 714 South Broadwell Avenue, Grand Island, NE 68803-6243 Ph: (308) 383-7000 |
News Archive
With just $399 and a bit of saliva in a cup, consumers can learn about their genetic risk for diseases from breast cancer to diabetes. Now, thanks to social networking sites set up by personal genomics companies, they can also share that information with family, friends and even strangers on the Internet.
Medicare coverage and nationwide utilization of computed tomographic colonography, commonly referred to as virtual colonoscopy, has tripled in recent years, according to a study in the April issue of the Journal of the American College of Radiology.
AstraZeneca and Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) recommends the investigational medicine metreleptin for the treatment of pediatric and adult patients with generalized lipodystrophy (LD).
The low oxygen concentrations that prevail in many tumors enhance their propensity to metastasize to other tissues. Researchers at Ludwig-Maximilians-Universitaet in Munich led by Professor Heiko Hermeking have now uncovered the molecular mechanism that links the two phenomena.
IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced another step in the implementation of its strategy to expand its product line for treating patients with peripheral vascular disease with the addition of two longer stents to its SUPERA product line.
› Verified 9 days ago